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ABSTRACT 
Background: Pituitary surgery is the most common surgery used to remove pituitary 
tumours. The use of mini doppler in surgical removal of an endonasal pituitary 
tumour has shown good short-term clinical outcomes and few complications in 
patients. Cavernous sinus invasion limits the surgical excision and still a challenge of 
gross total resection.   
Objective: The main objective of this study is to evaluate the outcome of surgical 
removal of an endonasal pituitary tumour using mini doppler.    
Method: A total of 12 patients were studied retrospectively from 2012 to 2018 in a 
single institution (Private hospital) in Dhaka, Bangladesh. The male and female ratio 
was 7:5. 
Results: 92% of cases of the total number of patients had satisfactory removal/ 
neurological improvement/hormonal improvement. Among 12 cases, 8 cases had 
transient diabetes insipidus and one patient had CSF leak.    
Conclusion: The intraoperative Doppler is a useful tool to localize the carotids, which 
provides safer resection of endonasal pituitary tumours. Thus, it is very safe and 
effective for laterosellar resection of recurrent pituitary tumours and for cavernous 
sinus invasions. 
 
 
INTRODUCTION 
Pituitary tumours are unusual growths that occur in your pituitary 
gland. Recurring pituitary adenomas can cause visual problems to re-
emerge, as well as the loss of pituitary function. It is generally divided 
into three categories depending upon their biological functioning: 
benign adenoma, invasive adenoma, and carcinomas. Most adenomas 
or tumours are benign, about 35% are invasive and just 0.1% to 0.2% 
are carcinomas.1 Since the initial description of a transnasal method for 
pituitary tumour care in 1907, transsphenoidal surgery has undergone 
continuous development, marked by close collaboration between 
neurosurgeons and otolaryngologists. Painful excentric muscle training 
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and ultrasound (US) and doppler-guided sclerosing 
injections of polidocanol have shown good clinical 
results, and the traditional surgical approaches have 
been less necessary.1-3 In 1910, Oskar Hirsch 
developed a lateral endonasal approach which he 
initially conducted as a five-step procedure over 
several weeks before simplifying the procedure with 
a single step submucosal transseptal approach.4 For 
many years, the conventional surgical treatment of 
mid-stage Achilles tendinosis consisted of a dorsal 
approach with central longitudinal tenotomy and tea 
excision.5-7 A pilot study using an US and 
dopplerguided scraping technique combined with a 
short rehabilitation period showed promising 
results.8 The scraping technique is based on the 
same findings that started the sclerosing polidocanol 
injection treatment, where gray-scale Us and doppler 
showed a relationship between vessels and nerves 
on the ventral side of the Achilles and chronic tendon 
pain. 9-11 Endoscopic endonasal pituitary surgery for 
the treatment of recurrent pituitary tumours is 
becoming increasingly common. The endoscopic 
endonasal transsphenoidal approach (eTSS) allows 
for more panoramic viewing and wider access to the 
base of the skull.12 Pituitary adenomas are most 
often classified as functional or non-functional, 
depending on their pattern of hormonal secretion. 
We addressed the safety and effectiveness of mini 
doppler in recurrent pituitary in this study and this 
doppler is commonly used in neurosurgical practice 
at present. It is a safe and non-invasive testing tool 
for cerebrovascular diseases. It is used to examine 
parameters of the blood flow, to diagnose stenosis, 
occlusion, and deformity of major head and neck 
arteries. Doppler ultrasound in carotid and 
measures both qualitative and quantitative blood 
flow parameters vertebral arteries, and other forms 
of care. 13-14 Nowadays the application of Doppler 
ultrasonography is becoming increasingly important 
in endoscopic transsphenoidal surgery. And that is 
indeed a safe and effective strategy. This study aims 
to evaluate the outcome of surgical removal of an 
endonasal pituitary tumour using mini doppler.  
 
METHODS 
A retrospective chart review was performed on 12 
patients who underwent surgical removal of an 
endonasal pituitary tumour using mini doppler 
between 2012 and 2018 in a single institution 
(Private hospital) Dhaka, Bangladesh. Informed 
consent from the patients to archive and process 
personal data in anonymous form was obtained.  
Inclusion criteria were, namely: patients 
developed recurrence of the tumour with symptoms 
like headache, vomiting, visual disturbances or 
hormonal imbalances. Exclusion criteria were, 
namely: Asymptomatic recurrence of the tumour. 
Follow up was carried out with routinely MRI of the 
brain with contrast performed in 1, 6 and 12 months. 
Then yearly for all patients. Minimum follow up in 
this study was 2 years. The hormonal study was 
assessed by an endocrinologist for functional 
tumours monthly for the first few months and then 
every 6 months and according to clinical 
manifestations.  
 
OPERATIVE PROCEDURE 
For all 12 patients, the same procedure was carried 
out as follows. The endonasal transsphenoidal 
approach was done using the binostril technique. 
Anatomical landmarks are posterior choana on both 
sides, from there 1.5 cm above the mucosal flap with 
scar tissue were separated and in the midline part of 
the keel of the sphenoid and the sphenoidal bony 
defects were identified. A high-speed drill to enlarge 
the defect and to localize the internal carotid arteries 
mini doppler was used. For recurrent tumours it’s 
difficult to localize particularly in the cavernous sinus 
and with the help of mini doppler medial 
opticocarotid recess (MOCR) can be identified and 
hence the tumour removal became safer. In some 
cases, where the tumour extended beyond the 
carotid, the whole of the artery was exposed by 
drilling and the tumour was removed from the lateral 
side. Cavernous sinus invasions were removed by 
localisation of carotid through mini doppler and 
opening up of cavernous sinus and through two 
suckers in two hands, along the longitudinal axis of 
artery tumour was removed to avoid injury to the 
cranial nerves. Bleeding from cavernous sinus was 
stopped by using fibrillar surgicel. A fascia was taken 
from the thigh and fibrin glue was used for dural 
closure. 
 
POSTOPERATIVE COMPLICATIONS AND MANAGEMENT 
Diabetes insipidus (DI)  
● If the consecutive three hours the urine output ≥ 
250 ml then injection Vasopressin 5 IU 
intramuscular was given. 
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● After 48 hours when the nasal pack was removed 
Desmopressin nasal spray was used 2 puff in one 
nostril and according to urine output. 
● Half strength normal saline IV was used to reduce 
the sodium level. 
● Avoidance of Hydrocortisone IV to minimize the 
DI except for those cases where the cortisol level 
was low.  
● In all cases the DI was transient and over one to 
two weeks the urine output became normal.  
 
For the CSF leak, the patient was managed with 
lumbar drainage with bed rest which was failed and 
re-exploration was done through an endoscopic 
approach to seal the leak with dural substitute and 
glue.  
Patient with little residual tumour was followed 
up with contrasted-MRI of the brain every 6 months 
and found no recurrence of size nor symptoms for 
the last 3 years. 
 
RESULTS 
Characteristics of patients are summarized in Table 
1. It was reported that 8.33% of patients had a 
residual tumour and 91.67% total removal of 
tumours among all patients. Among 12 cases, 8 cases 
had transient diabetes insipidus and one had CSF 
leak (Figure 1). 
 
Table 1. Characteristics of patients. 
 
Pt  Sex, age  Surgery 
year  
 Clinical presentation  Type of tumour Complication  Follow-up  
1  Male,45  2012  Headache, visual 
disturbance  
Non-functional  
Transient DI 
adenoma  
No  
residual  
2  Male,38  2013  Weight loss, 
tachycardia, 
irritability  
TSH secreting 
tumour  
Transient DI  No  
residual 
Normal level of 
hormone  
3  Male,28  2014  Headache,  
Vomiting, visual loss  
Non-functional 
tumour apoplexy  
Transient DI  No  
residual  
4  Male,32  2015  Abnormal growth 
of hands and feet  
Growth 
hormone-secreti ng 
tumour  
Transient DI  No  
residual 
Normal level of 
hormone  
5  Male,52  2016  Headache  Non-functional 
tumour  
CSF leak  
VIth nerve palsy  
No  
residual  
  
6  Male,36  2017  Headache, visual 
disturbance  
Non-functional 
tumour  
Transient DI  No  
residual  
  
7  Male,26  2017  Headache, vomiting  Non-functional 
tumour apoplexy  
Transient DI  Small 
residual  
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8  Female,25  2012  Amenorrhoea  Prolactinoma  None  No  
residual 
Normal level of 
hormone  
9  Female,30  2013  Infertility  Prolactinoma  None  No  
residual 
Normal level of 
hormone  
10  Female,42  2017  Headache  Non-functional 
tumour  
Transient DI  
  
No  
residual  
  
11  Female,24  2018  Headache  Cortisol 
secreting tumour  
None  No  
residual  
  
12  Female,43  2018  Headache  Non-functional 
adenoma  
Transient DI  No  
residual  
  
 
 
Table 2. Complication rates in male and female patients. 
 
Gender  DI  Postoperative hormonal 
deficiency  
Residual Tumour  
Male  6  None  1  
Female  2  None  0  
 
 
Table 3. Tumour resection types. 
 
Tumour type Cavernous Sinus 
invasion 
Gross 
total 
removal 
Cranial Nerve Injury 
    
Non- 
Functional 
4 3 1(VIth nerve) 
Functional None All None 
 
*Incomplete removal of one non-functional tumour was due to adherence of tumour with cranial nerve inside the cavernous sinus. 
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COMPLICATIONS 
The total number of patients was 12 in this study and among them, 8 patients had Diabetes Insipidus and 1 
patient had CSF leak. There were 6 male patients and 2 female patients having DI. 
 
 
Figure 1. Bar charts showing the number of patients having diabetes insipidus.  
 
In the figure (2A), intraoperative image showing the safe incision line in the midline and the probe, blue arrow 
touched is the safe incision line. And in figure (2B), contrast MRI brain T1 weighted image in sagital section is 
showing recurrent pituitary tumour.  
 
 
 
Figure 2 (A, B). Intraoperative image and MRI image of recurrent pituitary tumour. 
 
DISCUSSION 
The mini doppler controlled surgical removal of an 
endonasal pituitary tumour has shown good short-
term clinical outcomes and few complications in 
patients at varying levels of activity. With this 
treatment method, rapid pain relief and a return to 
even high-level sporting activity are feasible. The 
technique provides the greatest degree of freedom 
and efficiency at specific anatomical goals for sagittal 
surgery. This method is one step better for the 
treatment of recurrent pituitary tumours for 
improved quality and hospital stay time. More 
quantitative and qualitative data are required for 
calculating better results. In reaction to the 
procedure, athletes back in full pain-free training and 
competition are found to have a good result. The 
follow-up period after surgery was also not long, and 
with time, further failures could occur. Ongoing 
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research will concentrate on longer-term clinical 
outcomes and impacts on the thickness and function 
of the tendons. By using this strategy, since these 
lesions typically displace the optical apparatus away 
from the surgeon, tumour removal will begin 
craniopharyngioma and preexisting growth 
hormone and gonadal deficiencies experienced a 
complete failure of anterior pituitary function and DI 
following surgery immediately after opening the 
dura mater, resulting in prompt chiasm 
decompression. The early decompression probably 
allows the removal of any tumour adherent to the 
optical apparatus and/or its arachnoidal and 
vascular connections with less chance of visual 
degradation. This approach requires minimal nasal 
mucosal dissection, resulting in fewer sinonasal 
complications and a quicker and less painful 
rhinological recovery.15-16There are a variety of 
vascular problems associated with an approach 
through the nose and sublabial route use. The major 
drawback to the direct endonasal route is the fairly 
narrow and slightly off-midline direction of 
operation.17 This issue was largely solved by several 
technical innovations, including the use of low-profile 
micro-dissection instruments and cutting blades and 
the use of mini-dopplers, the use of angled 
endoscopes for more panoramic cephalad and 
lateral visualization beyond the microscope's tunnel 
vision, and the use of intraoperative surgical 
navigation to validate surgical trajectory and main 
land making. 18 Unfortunately, the complete removal 
by any method in the three other patients was not a 
realistic goal given the size and invasiveness of the 
tumours. Some of the patients in this series 
encountered new permanent endocrinological 
abnormalities, with the new DI occurring in 8 cases. 
Preservation of pituitary function in such patients is 
challenging particularly those in whom the anterior 
pituitary function has already failed.19 In our series of 
12 patients, the complication rate was low. A 
common clinical complication in our series was a 
postoperative CSF leak that occurs in 1 patient who 
had neurological defcits, including new cranial nerve 
palsy. Skin incision or brain retraction is also no 
longer required. These benefits lead to a decrease in 
complications, faster patient recovery, minimal 
postoperative discomfort and a decrease in overall 
costs. The cavernous sinus extension limits the 
excision of tumour and adjuvant radiotherapy is the 
alternate choice of treatment.20  
CONCLUSION 
The intraoperative Doppler is a useful tool to localize 
the carotids, which provides safer resection of 
endonasal pituitary tumours. Thus, it is very safe and 
effective for laterosellar as well as removal of 
intracavernous portions of tumour by two hand 
technique.  
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